A corporate pharmaceutical synergy orchestra that MP has joined with Dr. Frost being the orchestra leader.
Innovative formulations are the name of the game and this network of companies will systematically envelop each and every niche market for their formulations while keeping COGS down to an efficient minimum.
MP will now be more able to develop new product lines and fine tune existing ones with less costs associated with both.